{ "story_id": "250a52d6169e6f9d816b1e06b118d782", "desk": "drm3", "revision": 2, "published_at": "2026-09-02T15:02:00.000Z", "content_hash": "0f22630ed194c2fd2377026953a42f619b74b3b67fcc2df6f4d2dca7f3b97794", "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs", "basis": { "headline": "New Weight-Loss Pill Approved in Germany Amid Japan Debt Concerns", "dek": "Germany becomes first EU nation to approve Semaglutid tablets, while Japan faces currency crisis fears.", "prose": "Japan has the highest debt-to-GDP ratio in the world, exceeding double the amount the country produces annually. [^1]\n\nThe active ingredient Semaglutid, previously available as the injection Ozempic or Wegovy, is now approved in tablet form in Germany. [^2]\n\nFake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals. [^3]\n\nThe Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales. [^4]\n\nResearch presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications. [^5]\n\nThe study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed. [^6]\n\nSemaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria. [^7]\n\nGermany is the first European Union country to allow the weight-loss pill. [^8]\n\nSatsuki Katayama, Japan's Finance Minister, stated that the US and Japan jointly purchased yen to stabilize the currency. [^9]\n\nConsumers are advised to check for batch code RT6KL87 on packaging and never apply the injection if found, contacting a pharmacist immediately instead. [^10]\n\nHistorical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness. [^11]\n\nJairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone. [^12]", "cited": "[{\"statement\":\"Japan has the highest debt-to-GDP ratio in the world, exceeding double the amount the country produces annually.\",\"source\":\"DIE ZEIT\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T04:00:40.000Z\",\"publisher_count\":1,\"sources\":[\"DIE ZEIT\"]},{\"statement\":\"The active ingredient Semaglutid, previously available as the injection Ozempic or Wegovy, is now approved in tablet form in Germany.\",\"source\":\"DIE ZEIT\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T04:00:40.000Z\",\"publisher_count\":1,\"sources\":[\"DIE ZEIT\"]},{\"statement\":\"Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"The Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Research presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]},{\"statement\":\"The study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]},{\"statement\":\"Semaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria.\",\"source\":\"DER STANDARD\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T10:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"DER STANDARD\"]},{\"statement\":\"Germany is the first European Union country to allow the weight-loss pill.\",\"source\":\"DIE ZEIT\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T04:00:40.000Z\",\"publisher_count\":1,\"sources\":[\"DIE ZEIT\"]},{\"statement\":\"Satsuki Katayama, Japan's Finance Minister, stated that the US and Japan jointly purchased yen to stabilize the currency.\",\"source\":\"DIE ZEIT\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T04:00:40.000Z\",\"publisher_count\":1,\"sources\":[\"DIE ZEIT\"]},{\"statement\":\"Consumers are advised to check for batch code RT6KL87 on packaging and never apply the injection if found, contacting a pharmacist immediately instead.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Historical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Jairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]}]", "kind": "news" }, "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature", "receipt": null, "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record", "generation_chain": { "wire": { "stream": "fountain_news", "story_id": "a81e45f41cb589a1622855fb36005d0d", "thread_id": "50fae0dded41a2fc8a826242f203e5fb", "thread_label": "Semaglutid", "novelty": "UPDATE", "content_hash": "a9085e251393a8b6f8766dfaab2c56ad65a86fa89155967be45dcf52b74677b9", "last_published_at": "2026-09-02T15:02:00.000Z", "read_receipt": { "slice_hash": "faf23080a3705a54c4455c920d3885a108cf8d511e9854869962a86b07846359", "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDJUMTQ6NTY6MDAuMDAwMDAwWiIsImlkIjoiOTU0NGI0NzI4MTExNzc5ZjNlMWNkYTc2OTkzMDdiNTEiLCJ2IjoiMSJ9", "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDJUMTU6MjA6MTguMDAwMDAwWiIsImlkIjoiNzZlMDI5ZGRiMTIxNDdmODg2Y2EwNzE2MTZlNjViMzgiLCJ2IjoiMSJ9", "view": "v_fountain_news", "view_version": "1", "row_count": 100, "window_days": 3, "bytes_scanned": 10113494, "credits": 8, "price_per_100_rows": 8, "sig": "GCEWDeRpkk38WS444-GrSuVc1GWS0Om1Nuvycbkfn3jxu7v3Pm2YB5LYDMeWKTKRQUuqZUhYANLpGQtMGHluBA", "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE", "signer_path": "lakehouse/data-extract/v1", "alg": "Ed25519", "signed": true } }, "written_at": "2026-09-03T00:36:43.132Z" }, "cited_facts": [ { "statement": "Japan has the highest debt-to-GDP ratio in the world, exceeding double the amount the country produces annually.", "source": "DIE ZEIT", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T04:00:40.000Z", "publisher_count": 1, "sources": [ "DIE ZEIT" ] }, { "statement": "The active ingredient Semaglutid, previously available as the injection Ozempic or Wegovy, is now approved in tablet form in Germany.", "source": "DIE ZEIT", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T04:00:40.000Z", "publisher_count": 1, "sources": [ "DIE ZEIT" ] }, { "statement": "Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "The Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Research presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] }, { "statement": "The study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] }, { "statement": "Semaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria.", "source": "DER STANDARD", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T10:00:00.000Z", "publisher_count": 1, "sources": [ "DER STANDARD" ] }, { "statement": "Germany is the first European Union country to allow the weight-loss pill.", "source": "DIE ZEIT", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T04:00:40.000Z", "publisher_count": 1, "sources": [ "DIE ZEIT" ] }, { "statement": "Satsuki Katayama, Japan's Finance Minister, stated that the US and Japan jointly purchased yen to stabilize the currency.", "source": "DIE ZEIT", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T04:00:40.000Z", "publisher_count": 1, "sources": [ "DIE ZEIT" ] }, { "statement": "Consumers are advised to check for batch code RT6KL87 on packaging and never apply the injection if found, contacting a pharmacist immediately instead.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Historical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Jairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] } ], "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true." }